Yakir Rottenberg

1.6k total citations
82 papers, 1.0k citations indexed

About

Yakir Rottenberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yakir Rottenberg has authored 82 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Epidemiology. Recurrent topics in Yakir Rottenberg's work include Lung Cancer Treatments and Mutations (14 papers), Palliative Care and End-of-Life Issues (10 papers) and Cancer survivorship and care (10 papers). Yakir Rottenberg is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Palliative Care and End-of-Life Issues (10 papers) and Cancer survivorship and care (10 papers). Yakir Rottenberg collaborates with scholars based in Israel, United States and Netherlands. Yakir Rottenberg's co-authors include Jeremy M. Jacobs, Jochanan Stessman, Gil Goldzweig, Angela G. E. M. de Boer, Lea Baider, Tamar Peretz, Elisabeth Andritsch, Abraham J. Domb, Luna Kadouri and Eliana Ein‐Mor and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yakir Rottenberg

75 papers receiving 1.0k citations

Peers

Yakir Rottenberg
Xiaoling Wu China
Elizabeth J. Anderson United States
Charlene Thornton Australia
Guoxiang Liu China
Douglas J. Opel United States
Judith Hurley United States
Christopher Jackson New Zealand
Yo Han Lee South Korea
Barry S. Berman United States
Liyue Tong United States
Xiaoling Wu China
Yakir Rottenberg
Citations per year, relative to Yakir Rottenberg Yakir Rottenberg (= 1×) peers Xiaoling Wu

Countries citing papers authored by Yakir Rottenberg

Since Specialization
Citations

This map shows the geographic impact of Yakir Rottenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yakir Rottenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yakir Rottenberg more than expected).

Fields of papers citing papers by Yakir Rottenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yakir Rottenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yakir Rottenberg. The network helps show where Yakir Rottenberg may publish in the future.

Co-authorship network of co-authors of Yakir Rottenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Yakir Rottenberg. A scholar is included among the top collaborators of Yakir Rottenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yakir Rottenberg. Yakir Rottenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Agbarya, Abed, et al.. (2025). Real-World Data on Osimertinib-Associated Cardiac Toxicity. Journal of Clinical Medicine. 14(5). 1754–1754. 2 indexed citations
3.
Kumar, Awanish, Ariel M. Rubinstein, Jawad Abu-Tair, et al.. (2025). Effective head and neck cancer treatment combines radiation and local extended cisplatin release. Journal of Controlled Release. 384. 113923–113923.
4.
Dinstag, Gal, Yaron Kinar, Yakir Rottenberg, et al.. (2025). Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics. Journal for ImmunoTherapy of Cancer. 13(1). e010132–e010132. 1 indexed citations
5.
Ben‐Yehuda, Arie, et al.. (2024). Multimodal Machine Learning for Prediction of 30-Day Readmission Risk in Elderly Population. The American Journal of Medicine. 137(7). 617–628. 3 indexed citations
6.
7.
Nachmias, Boaz, et al.. (2023). Comparing end‐of‐life care of hematologic malignancy versus solid tumor patients in a tertiary care center. European Journal Of Haematology. 111(4). 528–535. 5 indexed citations
8.
Grinshpun, Albert, Tamar Hamburger, Tamar Sella, et al.. (2022). Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation. Oncology and Therapy. 10(2). 441–450. 2 indexed citations
9.
Moskovitz, Mor, Damien Urban, Hovav Nechushtan, et al.. (2021). dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50%. Clinical Lung Cancer. 23(2). 122–134. 17 indexed citations
10.
Tekale, Sunil U., et al.. (2021). Recent developments in biodegradable block copolymers. Polymers for Advanced Technologies. 32(10). 3877–3899. 8 indexed citations
11.
Baider, Lea, Gil Goldzweig, Jeremy M. Jacobs, et al.. (2021). Informal caregivers of older Muslims diagnosed with cancer: A portrait of depression, social support, and faith. Palliative & Supportive Care. 19(5). 598–604. 3 indexed citations
12.
Pollack, Rena, et al.. (2020). Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index. The Journal of Clinical Endocrinology & Metabolism. 105(10). e3620–e3627. 33 indexed citations
13.
Boer, Angela G. E. M. de, Steffen Torp, Trine Allerslev Horsbøl, et al.. (2020). Long-term work retention after treatment for cancer: a systematic review and meta-analysis. Journal of Cancer Survivorship. 14(2). 135–150. 76 indexed citations
14.
Kadouri, Luna, Yakir Rottenberg, Aviad Zick, et al.. (2019). Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization. Lung Cancer. 137. 48–51. 23 indexed citations
15.
Rottenberg, Yakir, Arash Naeim, Beatrice Uziely, Tamar Peretz, & Jeremy M. Jacobs. (2018). Breast cancer among older women: The influence of age and cancer stage on survival. Archives of Gerontology and Geriatrics. 76. 60–64. 14 indexed citations
16.
Rottenberg, Yakir, Navah Z. Ratzon, Miri Cohen, et al.. (2016). Unemployment risk at 2 and 4 years following colorectal cancer diagnosis: a population based study. European Journal of Cancer. 69. 70–76. 11 indexed citations
17.
Zick, Aviad, Tamar Peretz, Michal Lotem, et al.. (2016). Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients. Annals of Oncology. 27. vi26–vi26. 1 indexed citations
18.
Goldzweig, Gil, Lea Baider, Elisabeth Andritsch, Raphael Pfeffer, & Yakir Rottenberg. (2016). A Dialogue of Depression and Hope: Elderly Patients Diagnosed with Cancer and Their Spousal Caregivers. Journal of Cancer Education. 32(3). 549–555. 30 indexed citations
19.
Rottenberg, Yakir, Navah Z. Ratzon, Jeremy M. Jacobs, et al.. (2015). Unemployment risk and income change after testicular cancer diagnosis: A population-based study. Urologic Oncology Seminars and Original Investigations. 34(1). 5.e27–5.e33. 8 indexed citations
20.
Goldzweig, Gil, Yakir Rottenberg, Tamar Peretz, & Lea Baider. (2014). Silent Partners to Cancer Patients: Formal Caregivers and Oncologists. Journal of Cancer Education. 30(4). 704–710. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoling Wu Breakdown of academic impact, for papers by Elizabeth J. Anderson Breakdown of academic impact, for papers by Charlene Thornton Breakdown of academic impact, for papers by Guoxiang Liu Breakdown of academic impact, for papers by Douglas J. Opel Breakdown of academic impact, for papers by Judith Hurley Breakdown of academic impact, for papers by Christopher Jackson Breakdown of academic impact, for papers by Yo Han Lee Breakdown of academic impact, for papers by Barry S. Berman Breakdown of academic impact, for papers by Liyue Tong
Rankless by CCL
2026